Drawing based on the description in the official product monograph. No photo yet.
“40 mg tablets are light grey, film coated, round tablets debossed with "5340" on one side and "Ret 40" on the other.. The”
5340 Ret 40 pill
Pill with imprint 5340 Ret 40 is gray, round and has been identified as Selpercatinib 40 mg. It is used for lung cancer and thyroid neoplasms. It is supplied by Eli Lilly Canada Inc.
Sold in Canada
Selpercatinib 40 mg
- Brand
- Retevmo
- Imprint
- 5340 Ret 40
- Strength
- 40 mg
- Used for
- Lung cancer and thyroid neoplasms
- Color
- Gray
- Shape
- Round
- Form
- Capsule
- Manufacturer
- Eli Lilly Canada Inc
- Drug class
- Cancer medicine (kinase inhibitor)
- Sold in
- Canada
- DIN
- 02516918
Source: Health Canada's Drug Product Database and the official product monograph. Last checked .
Report a mistake
What is Selpercatinib used for?
Selpercatinib is used for lung cancer and thyroid neoplasms.
- Medicine type
- Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label
RET Fusion-Positive Non-Small Cell Lung Cancer
RETEVMO® is indicated for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with a rearranged during transfection (RET) gene fusion, as detected by an FDA-approved test.
RET-Mutant Medullary Thyroid Cancer
RETEVMO is indicated for the treatment of adult and pediatric patients 2 years of age and older with advanced or metastatic medullary thyroid cancer (MTC) with a RET mutation, as detected by an FDA-approved test, who require systemic therapy.
RET Fusion-Positive Thyroid Cancer
RETEVMO is indicated for the treatment of adult and pediatric patients 2 years of age and older with advanced or metastatic thyroid cancer with a RET gene fusion, as detected by an FDA-approved test, who require systemic therapy and who are radioactive iodine-refractory (if radioactive iodine is appropriate).
Other RET Fusion-Positive Solid Tumors
RETEVMO is indicated for the treatment of adult and pediatric patients 2 years of age and older with locally advanced or metastatic solid tumors with a RET gene fusion, as detected by an FDA-approved test, that have progressed on or following prior systemic treatment or who have no satisfactory alternative treatment options.
From the FDA-approved label on DailyMed (published Sep 14, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your pill? Check every detail
- Your pill shows 5340 Ret 40. The parts can be split between the two sides, so turn the pill over and check both.
- It is gray, round.
- Its score line and coating match the details on this page.
- It came from a pharmacy package that names the same drug.
Sold in Canada as Retevmo by Eli Lilly Canada Inc.
In Canada: prescription only.
Ingredients
Active: Selpercatinib
Pills that look similar but are different drugs
Same color and shape, different medicine. This is why the imprint matters.
-
A 50
Oxycodone 20 mg
Gray, round, 6 mm
Used for postoperative pain
Schedule II
-
G75
Oxymorphone Hydrochloride 7.5 mg
Gray, round, 5 mm
Used for pain
Schedule II
-
4941 V
Perphenazine 4 mg
Gray, round, 7 mm
Used for schizophrenia and psychosis
-
4942 V
Perphenazine 8 mg
Gray, round, 9 mm
Used for schizophrenia and psychosis
- APO OCD 15 Oxycodone Hydrochloride 15 mg Gray, round Used for postoperative pain
- ON 15 Oxycodone Hydrochloride 15 mg Gray, round Used for postoperative pain
Other Selpercatinib pills
- Ret120 6120 Selpercatinib 120 mg Purple, round, 9 mm Used for lung cancer and thyroid neoplasms
- Ret160 5562 Selpercatinib 160 mg Pink, round, 10 mm Used for lung cancer and thyroid neoplasms
- Lilly 3977 40mg Selpercatinib 40 mg Gray, capsule, 18 mm Used for lung cancer and thyroid neoplasms
- Ret40 5340 Selpercatinib 40 mg Gray, round, 6 mm Used for lung cancer and thyroid neoplasms
- Lilly 2980 80mg Selpercatinib 80 mg Blue, capsule, 22 mm Used for lung cancer and thyroid neoplasms
- Ret80 6082 Selpercatinib 80 mg Purple, round, 8 mm Used for lung cancer and thyroid neoplasms
- 6082 Ret 80 Selpercatinib 80 mg Purple & red, round Used for lung cancer and thyroid neoplasms
- 6082 Ret 80 Selpercatinib 80 mg Purple & red, round Used for lung cancer and thyroid neoplasms